V-115
Toward plug-and-play motor imagery-BCIs for rehabilitation: leveraging optimal transport for cross-subject adaptation
Catalina María Galván1,2, Ruben Daniel Spies1,2, Diego Humberto Milone3, Victoria Peterson1,2
  1. Instituto de Matemática Aplicada del Litoral, IMAL, UNL, CONICET, Santa Fe, Argentina
  2. Departamento de Matemática, Facultad de Ingeniería Química, UNL, Santa Fe, Argentina
  3. Instituto de Investigación en Señales, Sistemas e Inteligencia Computacional, sinc(i), FICH-UNL/CONICET, Argentina
Presenting Author:
Catalina María Galván
catalinamgalvan@gmail.com
Signal variability of electroencephalography (EEG)-based computer interfaces (BCIs), especially in motor imagery (MI) for rehabilitation, limits inter-subject generalization. Most MI-BCIs rely on intra-subject training, leading to long calibration sessions for each user. Even inter-subject transfer learning strategies, where large datasets are used to pretrain models, require substantial amounts of user-specific data to adapt and yield practical performance. Here, we present cross-subject backward optimal transport (XS-BOT), which extends backward optimal transport for domain adaptation to inter-subject transfer. Leveraging cued labels, XS-BOT aligns the features’ distribution of the target subject with the training features’ distribution, minimizing the amount of adaptation data and avoiding model retraining. XS-BOT was evaluated in two scenarios: cross-subject (multiple training subjects) and subject-to-subject (single training subject). For different base models, XS-BOT markedly outperformed the baselines using only 20 adaptation trials and three EEG channels. Cross-subject adaptation yielded accuracies similar to intra-subject setting, where a calibration session is needed. For subject-to-subject, results varied depending on the training subject, with cases that exceeded intra-subject results. By enabling accurate decoding with minimal calibration, XS-BOT moves MI-BCIs toward plug-and-play use in rehabilitation, supporting immediate feedback and longer therapy.